Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Immunopathol Pharmacol ; 22(1): 15-9, 2009.
Article in English | MEDLINE | ID: mdl-19309548

ABSTRACT

Autism spectrum disorder is of interest neurochemically because it represents a relatively homogeneous disorder with regard to disease development, abnormal cognitive development and intellectual development disturbance. A consistent finding in autistic children is a high number of mast cells and a high level of serotonin which is also found at elevated concentrations in the urine of autistic patients. In addition, a dysfunction of clinical conditions, such as gastrointestinal and immunological symptoms, is frequently noted in autistic children, however, IgE does not appear to be prevalent in these children but probably an increase of cytokines/chemokines produced by mast cells at an early age may play an important role. Therefore an immune hypothesis, involving also autoimmunity, is one possible pathogenetic mechanism in autism. In conclusion, mast cell activation could contribute to immune and neuroinflammatory abnormalities that are evident in patients with autism spectrum disorders.


Subject(s)
Autistic Disorder/immunology , Immunity , Ammonia/blood , Cytokines/biosynthesis , Humans , Mast Cells/physiology , Serotonin/physiology
2.
Pharmacol Res ; 55(1): 57-63, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17110126

ABSTRACT

Allergy is the result of a complex immune cascade leading to the disregulated production of Th2 cytokines, the generation of allergen-specific IgE-producing B cells and the subsequent activation and degranulation of mast cells upon allergen challenge. Mast cell effector function significantly influences the quantity, duration and magnitude of most allergic reactions. Here, using isolated human umbilical cord blood mast cells (HUCBMC) from CD34+ cells, activated with anti-IgE (10 microg/ml) in culture, we found an augmented release of IL-6, tryptase and histamine (p < 0.01 compared with control). In addition, in these cells anti-IgE (10 microg/ml) activated the expression of histidine decarboxylase (HDC) and IL-6. In these studies we describe a new biological activity of anti-IgE in inducing histidine decarboxylase and IL-6, suggesting that this cytokine may have an important effect on allergic and inflammatory diseases mediated by mast cells. Moreover, with these data we confirm the immunoregulatory and inflammatory function of mast cells.


Subject(s)
Fetal Blood/cytology , Histidine Decarboxylase/biosynthesis , Interleukin-6/biosynthesis , Mast Cells/immunology , RNA, Messenger/biosynthesis , Tryptases/metabolism , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Histamine Release/physiology , Histidine Decarboxylase/genetics , Humans , Immunoglobulin E/immunology , Mast Cells/enzymology , Microscopy, Electron, Transmission , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...